Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

Figure 3

Size of FAZ in DCP in the () and () groups and in the DME patients described as poor (, ) or good (, ) responders during subsequent intravitreal bevacizumab injections.